Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis

Padhmanand Sudhakar(KU Leuven), Séverine Vermeire(KU Leuven), Bram Verstockt(Universitair Ziekenhuis Leuven), João Sabino(KU Leuven), Sare Verstockt(KU Leuven), Jonathan Cremer(KU Leuven), Marc Ferrante(Universitair Ziekenhuis Leuven)
Inflammatory Bowel Diseases
December 14, 2020
10.1093/ibd/izaa281
Cited by 50

Related Papers

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
|Gut|2013|1.9k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k